Here's what is coming soon to NeurologyLive.
Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.
On Monday, November 16, 2020, Episode 14 of the “Rapid Readout: Expert Perspectives on Multiple Sclerosis - Data from the 8th Joint ACTRIMS-ECTRIMS Meeting 2020” series will go live. It is the third segment featuring Bianca Weinstock-Guttman, MD, who offered an overview of the data presented at the conference from the CLARITY extension trial of cladribine (Mavenclad; EMD Serono). As well, she provided insight into the potential role cladribine can play in disability improvement for patients with multiple sclerosis.
To catch up on the rest of the series, click here.
On Wednesday, November 18, 2020, at 7PM EDT, NeurologyLive (@neurology_live) will cohost a #MindMoments tweet chat with the LGS Foundation (@LGS_Foundation), Tuberous Sclerosis Alliance (@tsalliance), and the Dravet Syndrome Foundation (@curedravet) in celebration of Epilepsy Awareness Month. Use the hashtag #EpilepsyAwarenessChat to follow along with and take part in the conversation!
To follow us on Twitter, click here.
The fourth installment of our NeuroVoices series, dedicated to conversations with leaders in the neurology community, features Michael Irizarry, PhD, vice president, Clinical Research, Eisai. In the conversation, which will publish on Wednesday, November 18, 2020, he discussed the phase 3 trial of lorcaserin in patients with Dravet syndrome (DS), detailing the mechanism of the drug as a selective serotonin 5-HT2c receptor agonist, and how it went from being a major ingredient in Belviq—an FDA-approved weight-loss medication—to being prescribed as an off-label treatment for those with DS.
To check out the prior NeuroVoices conversations, click here.
A conversation with Barry Byrne, MD, PhD, chief medical advisor, Muscular Dystrophy Association (MDA), and associate chair of pediatrics and director, University of Florida Powell Center for Rare Disease Research and Therapy, will air on NeurologyLive's segment on the Medical World News channel this Thursday, November 19, 2020. Byrne discussed the MDA's recent telethon and the organization's efforts to increase awareness for neuromuscular diseases, in addition to offering some insight into the current state of care.
To check out previous conversations with Byrne, click here.
Episode 22 of the NeurologyLive "Mind Moments" podcast will air on Friday, November 20, 2020. The episode will feature an exclusive interview with Gerald Grant, MD, FACS, endowed professor in pediatric neurosurgery, Stanford University Medical Center, and Paul G. Fisher, MD, Beirne Family Professor of Pediatric Neuro-Oncology, professor of pediatrics, Stanford University Medical Center. The pair discussed the university's new pediatric neurology center, which will offer a multidisciplinary and cutting-edge approach to care for these patients.
To subscribe on your favorite podcast player, click here.